KCNK3 and multiple sclerosis: Based on the clearly positive staining of lymphocytes for TASK1/3, we can confirm that these K+- channels are expressed in lymphocytes and therefore play a significant role in the human immune response, which makes them a potential drug target for T cell-mediated autoimmune diseases such as multiple sclerosis [39].